Menu
Back to User profile » Dr Baorui Liu
Papers published by Dr Baorui Liu:
Lymphocyte-to-C Reactive Protein Ratio is an Independent Predictor of Survival Benefits for Hepatocellular Carcinoma Patients Receiving Radiotherapy
Shi Z, Zhu S, Jin Y, Qi L, Zhou M, Zhou Z, Zhang J, Liu B, Shen J
Journal of Hepatocellular Carcinoma 2024, 11:305-316
Published Date: 8 February 2024
Resumption of Intravenous Anti-Cancer Therapy in Breast Cancer: A Real-World Experience During the SARS-CoV-2 Pandemic
Yang F, Li C, Qiu Y, Chen X, Zheng K, Kang D, Zhang Y, Liu B, Yao Y, Xie L
Cancer Management and Research 2024, 16:1-9
Published Date: 3 January 2024
Efficacy and Safety of Sintilimab in Combination with Concurrent Chemoradiotherapy for Locally Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (SHARED): Study Protocol of a Prospective, Multi-Center, Single-Arm Phase 2 Trial
Wei J, Lu X, Liu Q, Fu Y, Liu S, Li L, Liu F, Fan X, Yang J, Yang Y, Zhao Y, Guan W, Liu B
Cancer Management and Research 2022, 14:2007-2015
Published Date: 17 June 2022
Combination Therapy with iRGD-antiCD3 and PD-1 Blockade Enhances Antitumor Potency of Cord Blood-Derived T Cells
Zhu M, Wang H, Zhou S, Wei J, Ding N, Shao J, Yu L, Feng Z, Liu B
OncoTargets and Therapy 2021, 14:835-844
Published Date: 5 February 2021
MicroRNA-200c Nanoparticles Sensitized Gastric Cancer Cells to Radiotherapy by Regulating PD-L1 Expression and EMT
Qian L, Liu F, Chu Y, Zhai Q, Wei X, Shao J, Li R, Xu Q, Yu L, Liu B, Liu Q
Cancer Management and Research 2020, 12:12215-12223
Published Date: 27 November 2020
Superior Antitumor Efficacy of IFN-α2b-Incorporated Photo-Cross-Linked Hydrogels Combined with T Cell Transfer and Low-Dose Irradiation Against Gastric Cancer
Liu Q, Zhang D, Qian H, Chu Y, Yang Y, Shao J, Xu Q, Liu B
International Journal of Nanomedicine 2020, 15:3669-3680
Published Date: 27 May 2020
Detection of PD-L1 Expression and Its Clinical Significance in Circulating Tumor Cells from Patients with Non-Small-Cell Lung Cancer
Cheng Y, Wang T, Lv X, Li R, Yuan L, Shen J, Li Y, Yan T, Liu B, Wang L
Cancer Management and Research 2020, 12:2069-2078
Published Date: 19 March 2020
Enhanced and Prolonged Antitumor Effect of Salinomycin-Loaded Gelatinase-Responsive Nanoparticles via Targeted Drug Delivery and Inhibition of Cervical Cancer Stem Cells
Wang Q, Liu F, Wang L, Xie C, Wu P, Du S, Zhou S, Sun Z, Liu Q, Yu L, Liu B, Li R
International Journal of Nanomedicine 2020, 15:1283-1295
Published Date: 26 February 2020
Hepatic Arterial Infusion Oxaliplatin Plus Oral S-1 Chemotherapy in Gastric Cancer with Unresectable Liver Metastases: A Case Series and Literature Review
Wang K, Zhang X, Wei J, Xu Y, Liu Q, Xie J, Yuan L, Sun Z, Tan S, Zhang L, Liu B, Yang Y
Cancer Management and Research 2020, 12:863-870
Published Date: 7 February 2020
Antitumor Activity of Thermosensitive Hydrogels Packaging Gambogic Acid Nanoparticles and Tumor-Penetrating Peptide iRGD Against Gastric Cancer
Zhang D, Chu Y, Qian H, Qian L, Shao J, Xu Q, Yu L, Li R, Zhang Q, Wu F, Liu B, Liu Q
International Journal of Nanomedicine 2020, 15:735-747
Published Date: 31 January 2020
Immune-Mediated Antitumor Effect By VEGFR2 Selective Inhibitor For Gastric Cancer
Yang J, Yan J, Shao J, Xu Q, Meng F, Chen F, Ding N, Du S, Zhou S, Cai J, Wang Q, Liu B
OncoTargets and Therapy 2019, 12:9757-9765
Published Date: 15 November 2019
Novel silk fibroin nanoparticles incorporated silk fibroin hydrogel for inhibition of cancer stem cells and tumor growth
Wu P, Liu Q, Wang Q, Qian H, Yu L, Liu B, Li R
International Journal of Nanomedicine 2018, 13:5405-5418
Published Date: 17 September 2018
Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment
Zhang Z, Qian H, Huang J, Sha H, Zhang H, Yu L, Liu B, Hua D, Qian XP
International Journal of Nanomedicine 2018, 13:4961-4975
Published Date: 31 August 2018